Latest News
Original English headlines · Newest first · U.S. Eastern Time
Corbus Pharmaceuticals Reports Q3 2026 Financial Results and Provides a Corporate UpdateMicware Co., Ltd. Announces First Half of Fiscal Year 2027 Financial Results#MWCKULR Reports Third Quarter 2026 Revenue of $7.4 Million, Up 197% Year-Over-Year, as Product Sales Nearly QuadrupleLichen International announces $3.5M registered direct offering; shares tumble#LICNExclusive: Metal-ceramic specialist Intalus expandingCurrent price of oil as of November 10, 2026Jensen Huang is the AI boom’s key man. Now, that’s a problem#NVDAArbutus Reports Third Quarter 2026 Financial Results and Provides Corporate UpdateNowVertical Group Reports Third Quarter 2026 Financial Results; Revenue Up 11% to $10.1 MillionXilio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Pipeline and Business Updates#XLOExagen Inc. Reports Third Quarter 2026 Financial Results#XGNBrainsWay Reports Third Quarter 2026 Financial Results and Operational HighlightsBetter targets $45M-$47M Q4 operating expenses as it projects $7.4M-$9.4M additional quarterly savings#BETRSally Beauty enters the holidays with positive sales momentumVenture Global plans to become the world’s largest gas exporter in a year—and now aims to build power for hyperscaler data centers#VGBots in the boardroom: Could an AI ever replace board directors?Gilat Reports Third Quarter 2026 ResultsCellectar Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates#CLRBBREAKING: Nvidia, $NVDA, CEO Jensen Huang's relationship with an alleged Chinese spy facilitated at least $7.5 billion in Nvidia chip shi...#NVDAHemab Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate UpdateBitdeer Reports Unaudited Third Quarter 2026 Results: Record Revenue of US$320.7 Million; Adjusted EBITDA Up 173% to US$69.6 MillionCullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results#CGEMOvid Therapeutics Reports Business Updates and Third Quarter 2026 Financial Results#OVIDHumacyte Reports Third Quarter 2026 Results, Highlighted by More Than Doubling Symvess Revenue and Expanding Commercial AdoptionAutolus Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates#AUTLHarvard Bioscience Announces Third Quarter 2026 Financial Results#HBIOLegend Biotech Reports Third Quarter 2026 Results and Recent Highlights#LEGNetoro Reports Third Quarter 2026 ResultsLENSAR® Reports Third Quarter 2026 Financial Results and Provides Business UpdateUpstream Bio Reports Third Quarter 2026 Financial Results and Highlights Continued Progress#UPBGain Therapeutics Reports Financial Results for Third Quarter 2026 and Provides Corporate Update#GANXCalciMedica Reports Third Quarter 2026 Financial Results and Provides Clinical & Corporate Updates#CALCSionna Therapeutics Reports Third Quarter 2026 Financial Results#SIONOpus Genetics Announces Financial Results for Third Quarter 2026 and Provides Corporate Update#IRDChicago Atlantic Real Estate Finance Announces Third Quarter 2026 Financial Results#REFIOlema Oncology Reports Third Quarter 2026 Financial and Operating ResultsImmatics Announces Third Quarter 2026 Financial Results and Business UpdateAI stocks bounce back — with one notable exception#NVDA← Previous